# Personalized Sertraline Dosing in Patients With Depression

> **NCT05210153** · — · WITHDRAWN · sponsor: **University of Belgrade**

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Sertraline

## Key facts

- **NCT ID:** NCT05210153
- **Lead sponsor:** University of Belgrade
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-07-16
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to slow rate of recruitment of patients with major depressive disorder in our site, it was not feasible to perform both planned Psycise studies. Therefore, all efforts were put into escitalopram study (Psycise-E).
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05210153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05210153, "Personalized Sertraline Dosing in Patients With Depression". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05210153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*